Age (y) | Range | 17–75 |
---|---|---|
Median | 36 | |
Sex | M/F | 3/31 |
Disease duration (y) | Range | 2–31 |
Median | 12 | |
Race | Whites | 30 |
Orientals | 4 | |
Blacks | 0 | |
ACR criterion22 | Number | % |
1 Malar rash | 14 | 41 |
2 Discoid rash | 6 | 18 |
3 Photosensitivity | 16 | 47 |
4 Oral ulcers | 2 | 6 |
5 Arthritis | 25 | 74 |
6 Pleuritis | 13 | 38 |
Pericarditis | 12 | 35 |
7 Proteinuria | 17 | 50 |
Cellular casts | 15 | 44 |
8 Convulsions | 2 | 6 |
Psychosis | 4 | 12 |
9 Haemolytic anaemia | 9 | 26 |
Leucocytopenia | 19 | 56 |
Lymphocytopenia | 14 | 41 |
Thrombocytopenia | 18 | 53 |
10 Anti-DNA antibodies | 34 | 100 |
Anti-Sm antibodies | 3 | 9 |
11 ANA | 34 | 100 |
The presence of the LE cell phenomenon and/or a false positive lues reaction is not included in the table as neither classification factor was routinely analysed in our follow up of SLE patients.